22.09
price up icon3.66%   0.78
after-market アフターアワーズ: 22.02 -0.07 -0.32%
loading
前日終値:
$21.31
開ける:
$21.21
24時間の取引高:
12.69M
Relative Volume:
1.69
時価総額:
$25.03B
収益:
$16.77B
当期純損益:
$-959.00M
株価収益率:
-11.04
EPS:
-2
ネットキャッシュフロー:
$1.37B
1週間 パフォーマンス:
+33.88%
1か月 パフォーマンス:
+29.71%
6か月 パフォーマンス:
+29.48%
1年 パフォーマンス:
+112.20%
1日の値動き範囲:
Value
$21.11
$22.17
1週間の範囲:
Value
$16.29
$22.17
52週間の値動き範囲:
Value
$10.34
$22.17

Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Company Profile

Name
名前
Teva Pharmaceutical Industries Ltd Adr
Name
セクター
Healthcare (1176)
Name
電話
972 (3) 914-8213
Name
住所
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
Name
職員
37,851
Name
Twitter
@TevaUSA
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
TEVA's Discussions on Twitter

TEVA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
22.09 25.03B 16.77B -959.00M 1.37B -0.85
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
164.84 74.37B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.69 43.81B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.10 41.53B 30.27B 1.93B 3.45B 0.6044
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
12.52 14.94B 15.05B -883.30M 1.89B -0.74

Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-07-10 アップグレード Argus Hold → Buy
2024-03-08 アップグレード JP Morgan Underweight → Neutral
2024-02-12 アップグレード Piper Sandler Neutral → Overweight
2024-01-23 アップグレード Jefferies Hold → Buy
2024-01-03 アップグレード Piper Sandler Underweight → Neutral
2023-12-18 開始されました HSBC Securities Buy
2023-11-27 アップグレード UBS Neutral → Buy
2023-07-06 アップグレード UBS Sell → Neutral
2023-05-25 開始されました Morgan Stanley Equal-Weight
2023-05-18 アップグレード Evercore ISI In-line → Outperform
2023-01-19 ダウングレード Jefferies Buy → Hold
2022-11-14 ダウングレード JP Morgan Neutral → Underweight
2022-11-04 ダウングレード UBS Neutral → Sell
2022-10-21 再開されました Jefferies Buy
2022-08-05 アップグレード BofA Securities Neutral → Buy
2022-06-14 再開されました UBS Neutral
2022-05-17 アップグレード BofA Securities Underperform → Neutral
2022-05-04 ダウングレード Piper Sandler Neutral → Underweight
2022-04-05 アップグレード Barclays Equal Weight → Overweight
2022-03-25 アップグレード Bernstein Mkt Perform → Outperform
2022-01-27 ダウングレード Argus Buy → Hold
2021-10-28 ダウングレード Raymond James Outperform → Mkt Perform
2021-05-04 ダウングレード UBS Buy → Neutral
2021-04-07 再開されました RBC Capital Mkts Sector Perform
2020-11-25 開始されました Oppenheimer Perform
2020-08-06 アップグレード Barclays Underweight → Equal Weight
2020-07-27 再開されました Goldman Neutral
2020-06-01 アップグレード SunTrust Hold → Buy
2020-04-24 再開されました Citigroup Neutral
2020-04-06 アップグレード UBS Neutral → Buy
2020-02-24 ダウングレード Edward Jones Hold → Sell
2019-11-12 アップグレード JP Morgan Underweight → Neutral
2019-10-17 アップグレード Gabelli & Co Hold → Buy
2019-08-07 ダウングレード Evercore ISI Outperform → In-line
2019-07-19 開始されました Wolfe Research Peer Perform
2019-07-15 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-07-10 再開されました Credit Suisse Neutral
2019-07-05 アップグレード Argus Hold → Buy
2019-06-11 開始されました Barclays Underweight
2019-06-03 アップグレード Oppenheimer Perform → Outperform
2019-05-30 ダウングレード BofA/Merrill Buy → Underperform
2019-05-28 ダウングレード UBS Buy → Neutral
2019-03-20 開始されました SunTrust Hold
2019-03-07 再開されました UBS Buy
すべてを表示

Teva Pharmaceutical Industries Ltd Adr (TEVA) 最新ニュース

pulisher
Dec 20, 2024

My Top 10 Portfolio Holdings for 2025 - The Motley Fool

Dec 20, 2024
pulisher
Dec 18, 2024

Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 90-Plus RS Rating - Inkl

Dec 18, 2024
pulisher
Dec 16, 2024

Sandoz Group AG Sponsored ADR (SDZNY) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance

Dec 16, 2024
pulisher
Dec 13, 2024

Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet - Yahoo Finance

Dec 13, 2024
pulisher
Dec 13, 2024

Is Kingsoft Cloud (KC) Outperforming Other Computer and Technology Stocks This Year? - Yahoo Finance

Dec 13, 2024
pulisher
Dec 12, 2024

Opera Gains 27% in 3 Months: Should You Buy, Sell or Hold the Stock? - Yahoo Finance

Dec 12, 2024
pulisher
Dec 12, 2024

Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies - Yahoo Finance

Dec 12, 2024
pulisher
Dec 10, 2024

Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily

Dec 10, 2024
pulisher
Dec 09, 2024

Hello Group Inc. Sponsored ADR (MOMO) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance

Dec 09, 2024
pulisher
Dec 06, 2024

Are Medical Stocks Lagging Adagene (ADAG) This Year? - Yahoo Finance

Dec 06, 2024
pulisher
Dec 04, 2024

Teva Pharmaceutical ADR Gets Relative Strength Rating Upgrade - Inkl

Dec 04, 2024
pulisher
Nov 30, 2024

Saudi Arabia Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research

Nov 30, 2024
pulisher
Nov 30, 2024

Why Sony Group Corporation (SONY) Is One of the Best ADR Stocks to Invest in? - Yahoo Finance

Nov 30, 2024
pulisher
Nov 27, 2024

Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance

Nov 27, 2024
pulisher
Nov 26, 2024

New Strong Buy Stocks for November 26th - Yahoo Finance

Nov 26, 2024
pulisher
Nov 25, 2024

Why MINISO Group Holding Limited Unsponsored ADR (MNSO) Outpaced the Stock Market Today - Yahoo Finance

Nov 25, 2024
pulisher
Nov 23, 2024

Petrobras to Distribute R$ 20 Billion in Dividends - Yahoo Finance

Nov 23, 2024
pulisher
Nov 22, 2024

10 Stocks With the Largest Fair Value Estimate Increases After Q3 Earnings - Morningstar

Nov 22, 2024
pulisher
Nov 21, 2024

Is Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Outperforming Other Consumer Discretionary Stocks This Year? - Yahoo Finance

Nov 21, 2024
pulisher
Nov 20, 2024

Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance

Nov 20, 2024
pulisher
Nov 18, 2024

UK Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research

Nov 18, 2024
pulisher
Nov 15, 2024

XPeng Inc. Sponsored ADR (XPEV) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance

Nov 15, 2024
pulisher
Nov 13, 2024

Sea Limited Q3 Earnings Miss Estimates, Shares Rise on Revenue Growth - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

Such Is The Power Of CNH Industrial NV (NYSE: CNH) - Stocks Register

Nov 12, 2024
pulisher
Nov 12, 2024

Hannover Rueck SE Reports Strong 2024 Earnings Growth - Yahoo Finance

Nov 12, 2024
pulisher
Nov 11, 2024

11 New 4-Star Stocks - Morningstar

Nov 11, 2024
pulisher
Nov 06, 2024

'This Is A New Teva,' Says CEO. But Investors Don't Seem To Believe. - Investor's Business Daily

Nov 06, 2024
pulisher
Oct 31, 2024

XPeng Inc. Sponsored ADR (XPEV) Stock Moves -1.06%: What You Should Know - Yahoo Finance

Oct 31, 2024
pulisher
Oct 30, 2024

Where Do Analysts See Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Heading? - Stocks Register

Oct 30, 2024
pulisher
Oct 25, 2024

Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - GlobeNewswire Inc.

Oct 25, 2024
pulisher
Oct 25, 2024

Sea Limited Sponsored ADR (SE) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance

Oct 25, 2024
pulisher
Oct 24, 2024

Li Auto Inc. Sponsored ADR (LI) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance

Oct 24, 2024
pulisher
Oct 23, 2024

South Africa Central Nervous System Therapeutic Market Size & Outlook, 2028 - Grand View Research

Oct 23, 2024
pulisher
Oct 23, 2024

Is Alstom (ALSMY) Outperforming Other Transportation Stocks This Year? - Yahoo Finance

Oct 23, 2024
pulisher
Oct 21, 2024

Spain Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research

Oct 21, 2024
pulisher
Oct 21, 2024

Italy Central Nervous System Therapeutic Market Size & Outlook, 2028 - Grand View Research

Oct 21, 2024
pulisher
Oct 21, 2024

Germany Central Nervous System Therapeutic Market Size & Outlook, 2028 - Grand View Research

Oct 21, 2024
pulisher
Oct 21, 2024

Is EXL Service (EXLS) Stock Outpacing Its Business Services Peers This Year? - Yahoo Finance

Oct 21, 2024
pulisher
Oct 18, 2024

Is DMARKET Electronic Services & Trading (HEPS) Outperforming Other Retail-Wholesale Stocks This Year? - Yahoo Finance

Oct 18, 2024
pulisher
Oct 17, 2024

Is AllianceBernstein (AB) Stock Outpacing Its Finance Peers This Year? - Yahoo Finance

Oct 17, 2024
pulisher
Oct 16, 2024

Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 5.28 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - The DBT News

Oct 16, 2024
pulisher
Oct 15, 2024

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

Oct 15, 2024
pulisher
Oct 15, 2024

Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.

Oct 15, 2024
pulisher
Oct 15, 2024

Is American Outdoor Brands (AOUT) Outperforming Other Consumer Discretionary Stocks This Year? - Yahoo Finance

Oct 15, 2024
pulisher
Oct 14, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Oct 14, 2024
pulisher
Oct 14, 2024

Monitoring Teva- Pharmaceutical Industries Ltd. ADR (TEVA) after recent insider movements - Knox Daily

Oct 14, 2024
pulisher
Oct 11, 2024

Li Auto Inc. Sponsored ADR (LI) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance

Oct 11, 2024
pulisher
Oct 10, 2024

Views of Wall Street’s Leading Experts on Teva- Pharmaceutical Industries Ltd. ADR - SETE News

Oct 10, 2024
pulisher
Oct 10, 2024

Selling Buzz: Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Exec. VP, European Commercial Daniell Richard sells 98,943 shares of the company – Knox Daily - Knox Daily

Oct 10, 2024
pulisher
Oct 09, 2024

Qifu Technology Inc. ADR (QFIN) gets rating Initiated from Nomura - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 1.45 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - The DBT News

Oct 09, 2024

Teva Pharmaceutical Industries Ltd Adr (TEVA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$12.52
price up icon 3.22%
$135.42
price up icon 0.34%
drug_manufacturers_specialty_generic RDY
$15.37
price up icon 1.65%
$83.45
price down icon 0.82%
drug_manufacturers_specialty_generic TAK
$13.10
price up icon 0.69%
大文字化:     |  ボリューム (24 時間):